These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38918108)

  • 1. Predictors of long-term survival after resection of adenocarcinoma arising from intraductal papillary mucinous neoplasm and derivation of a prognostic model: An international multicenter study (ADENO-IPMN study).
    Lucocq J; Joseph N; Hawkyard J; Haugk B; White S; Lye J; Parkinson D; Mownah O; Menon K; Furukawa T; Hirose Y; Sasahira N; Inoue Y; Mittal A; Samra J; Sheen A; Feretis M; Balakrishnan A; Ceresa C; Davidson B; Pande R; Dasari B; Roberts K; Tanno L; Karavias D; Helliwell J; Young A; Marks K; Nunes Q; Urbonas T; Silva M; Gordon-Weeks A; Barrie J; Gomez D; van Laarhoven S; Nawara H; Doyle J; Bhogal R; Harrison E; Roalso M; Ciprani D; Aroori S; Ratnayake B; Koea J; Capurso G; Stättner S; Bellotti R; Alsaoudi T; Bhardwaj N; Rajesh S; Jeffery F; Connor S; Cameron A; Jamieson N; Gill A; Soreide K; Pandanaboyana S
    Surgery; 2024 Sep; 176(3):890-898. PubMed ID: 38918108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of Recurrence After Surgical Resection for Adenocarcinoma Arising From Intraductal Papillary Mucinous Neoplasia (IPMN) With Patterns of Distribution and Treatment: An International, Multicenter, Observational Study (ADENO-IPMN Study).
    Lucocq J; Hawkyard J; Robertson FP; Haugk B; Lye J; Parkinson D; White S; Mownah O; Zen Y; Menon K; Furukawa T; Inoue Y; Hirose Y; Sasahira N; Feretis M; Balakrishnan A; Zelga P; Ceresa C; Davidson B; Pande R; Dasari B; Tanno L; Karavias D; Helliwell J; Young A; Nunes Q; Urbonas T; Silva M; Gordon-Weeks A; Barrie J; Gomez D; van Laarhoven S; Doyle J; Bhogal R; Harrison E; Roalso M; Ciprani D; Aroori S; Ratnayake B; Koea J; Capurso G; Bellotti R; Stättner S; Alsaoudi T; Bhardwaj N; Jeffery F; Connor S; Cameron A; Jamieson N; Sheen A; Mittal A; Samra J; Gill A; Roberts K; Soreide K; Pandanaboyana S
    Ann Surg; 2024 Jul; 280(1):126-135. PubMed ID: 37873663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for adenocarcinoma arising from intraductal papillary mucinous neoplasia: multicentre ADENO-IPMN study.
    Lucocq J; Hawkyard J; Haugk B; Mownah O; Menon K; Furukawa T; Inoue Y; Hirose Y; Sasahira N; Feretis M; Balakrishnan A; Ceresa C; Davidson B; Pande R; Dasari B; Tanno L; Karavias D; Helliwell J; Young A; Nunes Q; Urbonas T; Silva M; Gordon-Weeks A; Barrie J; Gomez D; Van Laarhoven S; Robertson F; Nawara H; Doyle J; Bhogal R; Harrison E; Roalso M; Ciprani D; Aroori S; Ratnayake B; Koea J; Capurso G; Bellotti R; Stättner S; Alsaoudi T; Bhardwaj N; Rajesh S; Jeffery F; Connor S; Cameron A; Jamieson N; Sheen A; Mittal A; Samra J; Gill A; Roberts K; Søreide K; Pandanaboyana S
    Br J Surg; 2024 Apr; 111(4):. PubMed ID: 38659247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive carcinoma arising in intraductal papillary mucinous neoplasms of the pancreas: a matched control study with conventional pancreatic ductal adenocarcinoma.
    Yopp AC; Katabi N; Janakos M; Klimstra DS; D'Angelica MI; DeMatteo RP; Fong Y; Brennan MF; Jarnagin WR; Allen PJ
    Ann Surg; 2011 May; 253(5):968-74. PubMed ID: 21422912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
    Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
    Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience.
    Marsoner K; Haybaeck J; Csengeri D; Waha JE; Schagerl J; Langeder R; Mischinger HJ; Kornprat P
    BMC Cancer; 2016 Nov; 16(1):844. PubMed ID: 27809876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas: comparison with pancreatic ductal adenocarcinoma.
    Woo SM; Ryu JK; Lee SH; Yoo JW; Park JK; Kim YT; Yoon YB
    Pancreas; 2008 Jan; 36(1):50-5. PubMed ID: 18192881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte-to-Monocyte Ratio Predicts Survival for Intraductal Papillary Mucinous Neoplasm with Associated Invasive Carcinoma of the Pancreas: Results from a High-Volume Center.
    Cui M; Hu Y; Zheng B; Chen T; Dai M; Guo J; Zhang T; Yu J; Liao Q; Zhao Y
    Dig Surg; 2024; 41(3):111-121. PubMed ID: 38981458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for postoperative recurrence of intraductal papillary mucinous neoplasms of the pancreas based on a long-term follow-up study: proposals for follow-up strategies.
    Yogi T; Hijioka S; Imaoka H; Mizuno N; Hara K; Tajika M; Tanaka T; Ishihara M; Shimizu Y; Hosoda W; Yatabe Y; Niwa Y; Yoshimura K; Bhatia V; Fujita J; Yamao K
    J Hepatobiliary Pancreat Sci; 2015 Oct; 22(10):757-65. PubMed ID: 26148131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncocytic-type intraductal papillary mucinous neoplasms: a unique malignant pancreatic tumor with good long-term prognosis.
    Marchegiani G; Mino-Kenudson M; Ferrone CR; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
    J Am Coll Surg; 2015 May; 220(5):839-44. PubMed ID: 25840549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors, Patterns, and Timing of Recurrence Provide Insight into the Disease Biology of Invasive Carcinomas Arising in Association with Intraductal Papillary Mucinous Neoplasms.
    Habib JR; Kinny-Köster B; Amini N; Shoucair S; Cameron JL; Thompson ED; Fishman EK; Hruban RH; Javed AA; He J; Wolfgang CL
    J Gastrointest Surg; 2022 Nov; 26(11):2311-2320. PubMed ID: 35915375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of preoperative prognostic factors in patients with resectable invasive intraductal papillary mucinous carcinoma.
    Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
    Surgery; 2020 Dec; 168(6):994-1002. PubMed ID: 32139141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precursor Epithelial Subtypes of Adenocarcinoma Arising from Intraductal Papillary Mucinous Neoplasms (A-IPMN): Clinicopathological Features, Recurrence and Response to Adjuvant Chemotherapy.
    Lucocq J; Haugk B; Parkinson D; Darne A; Joseph N; Hawkyard J; White S; Mownah O; Menon K; Furukawa T; Inoue Y; Hirose Y; Sasahira N; Mittal A; Samra J; Sheen A; Feretis M; Balakrishnan A; Ceresa C; Davidson B; Pande R; Dasari BVM; Tanno L; Karavias D; Helliwell J; Young A; Nunes Q; Urbonas T; Silva M; Gordon-Weeks A; Barrie J; Gomez D; van Laarhoven S; Nawara H; Doyle J; Bhogal R; Harrison E; Roalso M; Ciprani D; Aroori S; Ratnayake B; Koea J; Capurso G; Bellotti R; Stättner S; Alsaoudi T; Bhardwaj N; Jeffery F; Connor S; Cameron A; Jamieson N; Roberts K; Soreide K; Gill AJ; Pandanaboyana S
    Ann Surg Oncol; 2024 Oct; 31(10):7023-7032. PubMed ID: 38961040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
    Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
    Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas.
    Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ
    Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas.
    Chari ST; Yadav D; Smyrk TC; DiMagno EP; Miller LJ; Raimondo M; Clain JE; Norton IA; Pearson RK; Petersen BT; Wiersema MJ; Farnell MB; Sarr MG
    Gastroenterology; 2002 Nov; 123(5):1500-7. PubMed ID: 12404225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term surveillance is necessary after operative resection for intraductal papillary mucinous neoplasm of the pancreas.
    Hirono S; Kawai M; Okada K; Miyazawa M; Shimizu A; Kitahata Y; Ueno M; Yanagisawa A; Yamaue H
    Surgery; 2016 Aug; 160(2):306-17. PubMed ID: 27236360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease spectrum of intraductal papillary mucinous neoplasm with an associated invasive carcinoma invasive IPMN versus pancreatic ductal adenocarcinoma-associated IPMN.
    Kang MJ; Lee KB; Jang JY; Kwon W; Park JW; Chang YR; Kim SW
    Pancreas; 2013 Nov; 42(8):1267-74. PubMed ID: 24308063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas.
    Poultsides GA; Reddy S; Cameron JL; Hruban RH; Pawlik TM; Ahuja N; Jain A; Edil BH; Iacobuzio-Donahue CA; Schulick RD; Wolfgang CL
    Ann Surg; 2010 Mar; 251(3):470-6. PubMed ID: 20142731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on Cancer Stage.
    Waters JA; Schnelldorfer T; Aguilar-Saavedra JR; Chen JH; Yiannoutsos CT; Lillemoe KD; Farnell MB; Sarr MG; Schmidt CM
    J Am Coll Surg; 2011 Aug; 213(2):275-83. PubMed ID: 21601488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.